In a step to narrow competition with Amazon (AMZN) Web Services and Alphabet’s (GOOGL) Google Cloud, Microsoft (MSFT) is bringing out faster artificial intelligence (AI) chips to perform computing tasks more quickly, besides helping people with disabilities. These chips, made by Microsoft’s long-time partner Intel (INTC), will be available for 42 cents an hour within Azure machine learning service.
The chips, which are used in the initiative called Project Brainwave, are expected to process images with AI models faster than Amazon or Google. They will help companies expand work on the cloud, besides allowing them to set up in their own locations a similar technology, providing more flexibility. This was announced by executive chief Satya Nadella at Microsoft’s annual conference for software developers.
Microsoft has already committed $25 million over the next five years on AI for accessibility programs to aid people with disabilities.
Earlier, a “Seeing AI” free app, which is being experimented by Microsoft to help people navigate using computer vision and narration, was introduced by Nadella at a prior Build conference. For deaf users, Microsoft’s translation tool provides real-time conversation captioning.
Apple (AAPL) and Google have been spending years on accessibility, utilizing AI for people with disabilities. As 90% of the computers are powered by Windows, Microsoft is focusing on AI to push the technology forward and connect it to various programs.
The AI technology has both benefits and potential dangers. The dangers were forewarned by Tesla (TSLA) chief Elon Musk, who had predicted that it could spark World War III. On the other hand, Facebook (FB) chief Mark Zuckerberg has said that AI would be used to sort photos, weed out bad behavior and to test apps. Microsoft is hoping to work on the technology’s positive side for a social cause, that also holds bigger market potential.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on